14P Preclinical evaluation of intermittent dosing regimens on antitumor and PD activity of SY-5609, a potent and selective oral CDK7 inhibitor, in ovarian cancer xenografts

14P Preclinical evaluation of intermittent dosing regimens on antitumor and PD activity of SY-5609, a potent and selective oral CDK7 inhibitor, in ovarian cancer xenografts

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 32; p. S365
Main Authors: Johannessen, L., Dworakowski, W., Sawant, P., Ke, N., Lefkovith, A., D'Ippolito, A., Eaton, M., Henry, S.H., Hodgson, G.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-09-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2021.08.292